CLDX logo

CLDXCelldex Therapeutics Inc.

$28.62
$1.31
(4.38%)
Today
Closed $28.62
$0.23
(0.80%)
After Hours
Updated: 06:58 PM EDT
EarningsAug 6
Mkt Cap$2.25B
Vol1.27M

About

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
198

Frequently Asked Questions

What is Market Cap of Celldex Therapeutics Inc.?
What is the 52-week high for Celldex Therapeutics Inc.?
What is the 52-week low for Celldex Therapeutics Inc.?
What is Celldex Therapeutics Inc. stock price today?
What was Celldex Therapeutics Inc. stock price yesterday?
What is the PE ratio of Celldex Therapeutics Inc.?
What is the Price-to-Book ratio of Celldex Therapeutics Inc.?
What is the 50-day moving average of Celldex Therapeutics Inc.?
How many employees does Celldex Therapeutics Inc. have?

Advertisement|Remove ads.